Fecal microbiota transplant, its usefulness beyond Clostridioides difficile in gastrointestinal diseases

Simple item page
dc.coverageDOI: 10.1016/j.gastrohep.2021.05.009
dc.creatorNúñez F., Paulina
dc.creatorQuera, Rodrigo
dc.creatorBay, Constanza
dc.creatorThomson, Pamela
dc.date2021
dc.date.accessioned2025-11-18T19:41:24Z
dc.date.available2025-11-18T19:41:24Z
dc.description<p>Fecal microbiota transplant (FMT) is currently recommended for recurrent Clostridioides difficile infection. However, it is interesting to acknowledge the potential therapeutic role in other diseases associated with dysbiosis. This review will focus on the current and potential indications of FMT in gastrointestinal diseases, evaluating the available evidence and also exposing the necessary requirements to carry it out.</p>eng
dc.identifierhttps://investigadores.uandes.cl/en/publications/39aa6b80-195e-4878-9613-31f2b96d565a
dc.identifier.urihttps://repositorio.uandes.cl/handle/uandes/51799
dc.languageeng
dc.rightsinfo:eu-repo/semantics/restrictedAccess
dc.sourcevol.45 (2021) nr.3 p.223-230
dc.subjectClostridioides difficile
dc.subjectFecal microbiota transplantation
dc.subjectGastrointestinal illness
dc.subjectMicrobiome
dc.titleFecal microbiota transplant, its usefulness beyond Clostridioides difficile in gastrointestinal diseaseseng
dc.titleTrasplante de microbiota fecal, su utilidad más allá de Clostridioides difficile en enfermedades gastrointestinalesspa
dc.titleFecal microbiota transplant, its usefulness beyond Clostridioides difficile in gastrointestinal diseaseseng
dc.typeArticleeng
dc.typeArtículospa
Files
Collections
PURE